IL114520A0 - Dinucleoside-5',5',-pyrophosphates - Google Patents

Dinucleoside-5',5',-pyrophosphates

Info

Publication number
IL114520A0
IL114520A0 IL11452095A IL11452095A IL114520A0 IL 114520 A0 IL114520 A0 IL 114520A0 IL 11452095 A IL11452095 A IL 11452095A IL 11452095 A IL11452095 A IL 11452095A IL 114520 A0 IL114520 A0 IL 114520A0
Authority
IL
Israel
Prior art keywords
riboside
dideoxy
pyrophosphates
azido
dinucleoside
Prior art date
Application number
IL11452095A
Other languages
English (en)
Original Assignee
Lepetit Spa
Univ Degli Studi Genova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa, Univ Degli Studi Genova filed Critical Lepetit Spa
Publication of IL114520A0 publication Critical patent/IL114520A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Dental Preparations (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL11452095A 1994-07-15 1995-07-10 Dinucleoside-5',5',-pyrophosphates IL114520A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94202059 1994-07-15

Publications (1)

Publication Number Publication Date
IL114520A0 true IL114520A0 (en) 1995-11-27

Family

ID=8217039

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11452095A IL114520A0 (en) 1994-07-15 1995-07-10 Dinucleoside-5',5',-pyrophosphates

Country Status (15)

Country Link
US (2) US6040297A (de)
EP (1) EP0773951B1 (de)
JP (1) JPH10502655A (de)
AT (1) ATE177431T1 (de)
AU (1) AU688552B2 (de)
CA (1) CA2195091A1 (de)
DE (1) DE69508255T2 (de)
ES (1) ES2129893T3 (de)
FI (1) FI970081A0 (de)
HU (1) HUT76331A (de)
IL (1) IL114520A0 (de)
NO (1) NO965483L (de)
NZ (1) NZ290127A (de)
WO (1) WO1996002554A1 (de)
ZA (1) ZA955826B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1262556C (zh) 1997-02-06 2006-07-05 印斯拜尔药品股份有限公司 特定的二核苷酸和它们作为粘膜纤毛清除和纤毛颤动频率调节剂的应用
US7223744B2 (en) * 1997-02-10 2007-05-29 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
US7078391B2 (en) * 1997-02-10 2006-07-18 Inspire Pharmaceuticals, Inc. Method of treating edematous retinal disorders
US6818629B2 (en) 1997-02-10 2004-11-16 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
US6596725B2 (en) 1997-02-10 2003-07-22 Inspire Pharmaceuticals, Inc. Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema
AU6551800A (en) * 1999-08-17 2001-03-13 Adani, Alexander Dinucleoside 5',5'-tetraphosphates as inhibitors of viral reverse transcriptasesand viruses
BRPI0003386B8 (pt) * 2000-08-08 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda pró-droga homo ou heterodiméricas úteis no tratamento de doenças ou disfunções mediadas por fosfodiesterases; composições farmacêuticas contendo a pró-droga ou seus sais farmacêuticos aceitáveis; processo de obtenção destas pró-drogas
US6867199B2 (en) 2000-08-21 2005-03-15 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapeutic use
US6555675B2 (en) 2000-08-21 2003-04-29 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
US7067148B2 (en) 2001-02-15 2006-06-27 King Pharmaceutical Research & Development, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US7790037B2 (en) * 2003-06-25 2010-09-07 University of Pittsburgh—of the Commonwealth System of Higher Education Separation of compounds using tagging moieties including varying numbers of repeat units
IL322998A (en) 2019-09-05 2025-10-01 Mitorainbow Therapeutics Inc Treatment of mitochondrial DNA depletion disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321462A (en) * 1963-07-15 1967-05-23 Syntex Corp Process for the preparation of nucleoside polyphosphates
US3506478A (en) * 1968-08-29 1970-04-14 Budd Co Method of balancing a brake drum
US4855304A (en) * 1985-01-10 1989-08-08 Repligen Corporation Dinucleoside pyrophosphates and pyrophosphate homologs as plant antivirals
US5159067A (en) * 1987-01-28 1992-10-27 University Of Georgia Research Foundation Inc. 5'-Diphosphohexose nucleoside pharmaceutical compositions
CA1330794C (en) * 1987-03-27 1994-07-19 Phillip Frost Anti-viral compounds, dosage forms and methods
IL86650A0 (en) * 1987-06-30 1988-11-30 Biophor Corp Animal derived cells and liposomes,having an antigenic protein incorporated into their membrane
EP0375183A1 (de) * 1988-12-05 1990-06-27 Schering Corporation Antivirale Dimere und Trimere
NZ233197A (en) * 1989-04-13 1991-11-26 Richard Thomas Walker Aromatically substituted nucleotide derivatives, intermediates therefor and pharmaceutical compositions
DK0517986T3 (da) * 1991-06-14 1998-03-30 Europ Communities Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater
US5521161A (en) * 1993-12-20 1996-05-28 Compagnie De Developpment Aguettant S.A. Method of treating HIV in humans by administration of ddI and hydroxycarbamide

Also Published As

Publication number Publication date
HUT76331A (en) 1997-08-28
WO1996002554A1 (en) 1996-02-01
NO965483L (no) 1997-01-28
AU3076695A (en) 1996-02-16
CA2195091A1 (en) 1996-02-01
HU9700118D0 (en) 1997-02-28
FI970081A7 (fi) 1997-01-08
EP0773951A1 (de) 1997-05-21
EP0773951B1 (de) 1999-03-10
DE69508255T2 (de) 1999-10-14
DE69508255D1 (de) 1999-04-15
FI970081L (fi) 1997-01-08
NO965483D0 (no) 1996-12-19
US6080731A (en) 2000-06-27
MX9700360A (es) 1998-03-31
ZA955826B (en) 1996-02-21
ATE177431T1 (de) 1999-03-15
AU688552B2 (en) 1998-03-12
JPH10502655A (ja) 1998-03-10
US6040297A (en) 2000-03-21
NZ290127A (en) 1998-05-27
ES2129893T3 (es) 1999-06-16
FI970081A0 (fi) 1997-01-08

Similar Documents

Publication Publication Date Title
HU9700118D0 (en) Dinucleoside-5',5'-pyrophosphates
HK1038744A1 (zh) 用於治療炎性疾病的化合物
IL78158A (en) Pharmaceutical compositions containing 3'-azido-3'-deoxythymidine
IT8421982A0 (it) Strumento per l'estrazione di corpi estranei da canali fisiologici dell'organismo.
AU4282996A (en) Mesoscale devices for analysis of motile cells
EP0695758A3 (de) Pentapeptid-Amide und -Ester, die menslichen Krebs hemmen
CA2174494A1 (en) Benzofurans
GB9813540D0 (en) Chemical compounds
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
IT8419316A0 (it) Dispositivo per variare la flessibilita' particolarmente per scarpe da sci.
KR960009930B1 (en) 5'-phosphonates of 3'-azido-2,'3'-dideoxynucleosides
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
NZ224189A (en) 6-substituted 2',3'-dideoxynucleosides and pharmaceutical compositions
ES8604258A1 (es) Un procedimiento para preparar una adenosina sustituida en n6
FR2753911B1 (fr) Procede de preparation d'une composition antimousse encapsulee, et composition ainsi preparee
MX9800049A (es) Antraquinonas mono- y disulfo-substituidas y su uso para el tratamiento de trastornos de la matriz del hueso.
FR2567884B1 (fr) Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
IT1136889B (it) Mietitrebbiatrice per l'ottenimento di mais da granella
NO952576D0 (no) Vanillin- og/eller etylvanillinperler og fremgangsmåte for deres fremstilling
IT1241631B (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
ES2128313T3 (es) Naftalimidas n-substituidas, su obtencion y empleo.
IT8022677A0 (it) Sostanze dotate di attivita'antispastica vasale e procedimenti per la loro preparazione.
AU3189199A (en) Antisense modulation of lfa-3
IL74388A (en) 2,3,4,5-tetrahydro-11-phenyl-1h-(1,4)diazepino(1,7-a)indoles,their production and pharmaceutical compositions containing them
FR2654429B1 (fr) Nouveaux derives du methyl-2-propionate de 3,3,5-trimethylcyclohexanol, leur procede de preparation ainsi que compositions therapeutiques les contenant.